# CYAB (Cyabra, Inc.) - SEC EDGAR Financial Statements

> Cyabra, Inc. reported $2.96M in total assets and a net loss of $8.46M through December 31, 2025 from SEC EDGAR filings.

- Canonical: https://convexityos.com/fundamentals/CYAB
- Markdown: https://convexityos.com/fundamentals/CYAB.md
- SEC CIK: 0002032341
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 21, 2026, 05:12 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0002032341&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | FY 2025 | -- | Dec 31, 2025 |
| Operating Income | FY 2025 | -$8.70M | Operating profit |
| Net Income | FY 2025 | -$8.46M | GAAP bottom line |
| Diluted EPS | FY 2025 | -$0.21 | Split-adjusted |
| Free Cash Flow | FY 2025 | -- | Operating CF less CapEx |
| Cash & ST Investments | Sep 30, 2026 | $1.34M | Total debt: $2.25M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Total Operating Expenses | $156K |
| **Operating Income** | -$156K |
| **Net Income** | -$156K |
| Basic EPS | -$156.35 |
| **Diluted EPS** | -$156.35 |
| Basic Shares Outstanding | 1.0K |
| Diluted Shares Outstanding | 1.0K |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $2.00M | $1.85M | $1.42M | -- | $1.49M | $1.33M | $1.26M |
| Cost of Revenue | $304K | $304K | $192K | -- | $175K | $213K | $196K |
| **Gross Profit** | $1.70M | $1.55M | $1.22M | -- | $1.31M | $1.12M | $1.06M |
| Research & Development | $2.17M | $2.06M | $5.51M | -- | $1.66M | $1.84M | $1.85M |
| Selling, General & Admin | $2.74M | $2.61M | $7.54M | -- | $1.81M | $2.70M | $3.25M |
| **Operating Income** | -$3.22M | -$3.12M | -$11.82M | $9.46M | -$2.16M | -$3.42M | -$4.04M |
| Income Before Tax | -$2.59M | -$3.38M | -$10.77M | -- | -$2.74M | -$2.43M | -$3.31M |
| Income Tax Expense | $1.0K | $64K | -- | -- | $1.0K | $19K | -- |
| **Net Income** | -$2.59M | -$3.44M | -$10.77M | $8.34M | -$2.74M | -$2.45M | -$3.31M |
| Basic EPS | -$0.13 | -$0.26 | -$3.10 | -- | -$1.07 | -$1.07 | -$1.47 |
| **Diluted EPS** | -$0.13 | -$0.26 | -$3.10 | -- | -$1.07 | -$1.07 | -$1.47 |
| Basic Shares Outstanding | 41.1M | 13.4M | 3.5M | -- | 2.7M | 2.4M | 2.4M |
| Diluted Shares Outstanding | 41.1M | 13.8M | 3.5M | -- | 2.7M | 2.4M | 2.4M |

## Balance Sheet

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 |
| --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $1.34M | $794K | $3.12M | $294K |
| **Cash & Short-Term Investments** | $1.34M | $794K | $3.12M | $294K |
| Accounts Receivable, Net | $433K | $568K | $216K | $269K |
| Other Current Assets | $603K | $593K | $241K | $152K |
| **Total Current Assets** | $2.40M | $1.98M | $3.77M | $737K |
| Property, Plant & Equipment, Net | $141K | $144K | $137K | $146K |
| Other Non-Current Assets | $94K | $99K | $125K | -- |
| **Total Non-Current Assets** | $560K | $653K | $755K | $721K |
| **Total Assets** | $2.96M | $2.63M | $4.53M | $1.46M |
| Accounts Payable | $1.05M | $2.02M | $2.48M | $1.77M |
| Short-Term Debt | $1.87M | $2.00M | $2.24M | $5.77M |
| Deferred Revenue (Current) | $2.78M | $3.45M | $2.29M | $2.82M |
| Other Current Liabilities | $1.25M | $1.21M | $1.18M | $94K |
| **Total Current Liabilities** | $10.89M | $13.85M | $16.36M | $25.48M |
| Deferred Revenue (Non-Current) | $586K | $683K | $41K | $115K |
| **Total Non-Current Liabilities** | $609K | $778K | $210K | $753K |
| **Total Liabilities** | $11.50M | $14.63M | $16.57M | $26.23M |
| **Total Debt (incl. Leases)** | $2.25M | $2.49M | $2.80M | $6.42M |
| Retained Earnings | -$64.17M | -$61.58M | -$58.14M | -$47.37M |
| **Total Stockholders' Equity** | -$8.54M | -$12.00M | -$12.05M | -$40.04M |
| Total Equity | -$8.54M | -$12.00M | -$12.05M | -$40.04M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 |
| --- | --- |
| Net Income | -$156K |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$2.59M | -$3.44M | -$10.77M | $8.34M | -$2.74M | -$2.45M | -$3.31M |
| Stock-Based Compensation | $706K | $223K | $4.21M | -- | $448K | $866K | $1.39M |
| Change in Receivables | $135K | -$352K | $53K | -- | $19K | -$195K | $26K |
| Change in Payables | -$330K | $120K | $709K | -- | -$35K | $522K | $157K |
| **Operating Cash Flow** | -$4.57M | -$2.40M | -$2.60M | -- | -$2.69M | -$2.56M | -$1.27M |
| Capital Expenditure | -$14K | -$23K | -$5.0K | -- | -$19K | -$17K | -$12K |
| **Free Cash Flow** | -$4.59M | -$2.42M | -$2.60M | -- | -$2.71M | -$2.58M | -$1.28M |
| **Investing Cash Flow** | -$13K | -$23K | -$5.0K | -- | -$18K | -$17K | -$12K |
| **Financing Cash Flow** | $5.15M | -$60K | $5.62M | -- | $2.50M | $2.07M | $1.06M |
| **Net Change in Cash** | $561K | -$2.48M | $3.02M | -- | -$214K | -$506K | -$225K |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Return on Assets (ROA) | -285.6% | -327.0% | -168.2% | -10.7% | -- | -- | -- |
| Current Ratio | 0.22x | 0.14x | 0.23x | 0.03x | -- | -- | -- |
| Quick Ratio | 0.16x | 0.10x | 0.20x | 0.02x | -- | -- | -- |
| **Revenue Growth (YoY)** | +34.7% | +39.2% | +12.3% | -- | -- | -- | -- |
| Gross Profit Growth (YoY) | +29.5% | +38.6% | +14.9% | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
